EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

41 hedge funds and large institutions have $11.4M invested in Eiger BioPharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less call options, than puts

Call options by funds: $ | Put options by funds: $

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7K
Puts
$11K
Net Calls
Net Calls Change

Top Buyers

1
+$2.15M
2
+$386K
3
+$103K
4
Citadel Advisors
Citadel Advisors
Florida
+$64.8K
5
ARTA
A.R.T. Advisors
New York
+$42K

Top Sellers

1
-$861K
2
-$500K
3
-$257K
4
TC
TFS Capital
Pennsylvania
-$66.4K
5
AL
Airain Ltd
Guernsey
-$38K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$25K
27
$21K
28
$20K
29
$17K
30
$15K
31
$7K
32
$5K
33
$5K
34
$5K
35
$3K
36
$3K
37
$2K
38
$1K
39
$1K
40
$1
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2